Evidence map›Paper›PMID 37005952›Full record

ReviewOncology and therapy2023

The Future of Breast Cancer Research in the Survivorship Field.

D Soldato, L Arecco, E Agostinetto, M A Franzoi, E Mariamidze, S Begijanashvili, N Brunetti, S Spinaci, C Solinas, I Vaz-Luis and 2 more

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Oncology and therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07140107 (Patients' Perceptions and Comprehension of Original Versus AI-Generated Plain Language Summaries of Cochrane Oncology Systematic Reviews), which is not on this map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07140107 naenrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Patients' Perceptions and Comprehension of Original Versus AI-Generated Plain Language Summaries of Cochrane Oncology Systematic Reviews

TypeinterventionalSponsorUniversity of Split, School of MedicineRan2025 to 2026Enrolled130ConditionsNon-Metastatic Breast CancerArmsAI-generated PLS, Original PLS
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 34 citations in OpenAlex.

  1. Synthesis of clinical practice guidelines and recommendations for breast cancer survivorship care: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. William Halsted's Radical Mastectomy Patients: A Historical Analysis Through Patient Narratives.Annals of surgery open : perspectives of surgical history, education, and clinical approaches · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Addressing the Needs of Breast Cancer Survivors.Current oncology reports · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

D SoldatoDepartment of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy.
L AreccoDepartment of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy.
E AgostinettoDepartment of Medical Oncology, Institut Jules Bordet and Université Libre de Bruxelles (U.L.B.), Brussels, Belgium.
M A FranzoiMolecular Predictors and New Targets in Oncology, Institut National de la Sante et de la Recherche Medicale Unit 981, Gustave Roussy, Villejuif, France.
E MariamidzeDepartment of Oncology and Hematology, Todua Clinic, Tbilisi, Georgia.
S BegijanashviliDepartment of Clinical Oncology, American Hospital Tbilisi, Tbilisi, Georgia.
N BrunettiDepartment of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
S SpinaciDivision of Breast Surgery, Villa Scassi Hospital, Genoa, Italy.
C SolinasMedical Oncology, AOU Cagliari, Policlinico Duilio Casula, Monserrato, Italy.
I Vaz-LuisMolecular Predictors and New Targets in Oncology, Institut National de la Sante et de la Recherche Medicale Unit 981, Gustave Roussy, Villejuif, France.
A Di MeglioMolecular Predictors and New Targets in Oncology, Institut National de la Sante et de la Recherche Medicale Unit 981, Gustave Roussy, Villejuif, France.
M LambertiniDepartment of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy. matteo.lambertini@unige.it.ORCID http://orcid.org/0000-0003-1797-5296
Inserm · FROspedale Policlinico San Martino · ITPoliclinico Casilino · ITSwedish American Hospital · USUniversité Libre de Bruxelles · BEUniversity of Genoa · ITVilla Torri Hospital · IT

Funding

Associazione Italiana per la Ricerca sul Cancro MFAG 2020 identification No. 24698
6 · The paper itself

Abstract

Prevalence of survivors of breast cancer has been steadily increasing in the last 20 years. Currently, more than 90% of women diagnosed with early-stage breast cancer are expected to be alive at 5 years from diagnosis thanks to early detection and breakthrough innovations in multimodal treatment strategies. Alongside this advancement in clinical outcomes, survivors of breast cancer might experience several specific challenges and present with unique needs. Survivorship trajectories after diagnosis and treatment of breast cancer can be significantly impacted by long-lasting and severe treatment-related side effects, including physical problems, psychological distress, fertility issues in young women, and impaired social and work reintegration, which add up to patients' individual risk of cancer recurrence and second primary malignancies. Alongside cancer-specific sequelae, survivors still present with general health needs, including management of chronic preexisting or ensuing conditions. Survivorship care should implement high-quality, evidence-based strategies to promptly screen, identify, and address survivors' needs in a comprehensive way and minimize the impact of severe treatment sequelae, preexisting comorbidities, unhealthy lifestyles, and risk of recurrence on quality of life. This narrative review focuses on core areas of survivorship care and discuss the state of the art and future research perspectives in key domains including selected long-term side effects, surveillance for recurrences and second cancers, well-being promotion, and specific survivors' needs.

Indexed as

Breast cancerSupportive careSurvivorship

Identifiers

PMID37005952
PMCPMC10260743
OpenAlexW4362506993

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.